Literature DB >> 18628490

Francisella tularensis: unravelling the secrets of an intracellular pathogen.

Petra C F Oyston1.   

Abstract

Francisella tularensis has been recognized as the causative agent of tularaemia for almost a century. Since its discovery in 1911, it has been shown to infect a wide range of hosts, including humans. As early as the 1920s it was suggested to be an intracellular pathogen, but it has proven to be an enigmatic organism, whose interaction with the host has been difficult to elucidate, and we still have a very limited understanding of the molecular mechanisms of virulence. However, the recent availability of genome sequence data and molecular tools has allowed us to start to understand the molecular basis of F. tularensis pathogenicity, and will facilitate the development of a vaccine to protect against infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18628490     DOI: 10.1099/jmm.0.2008/000653-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  73 in total

1.  Increased Resistance to Intradermal Francisella tularensis LVS Infection by Inactivation of the Sts Phosphatases.

Authors:  Kaustubh Parashar; Erik Kopping; David Frank; Vinaya Sampath; David G Thanassi; Nick Carpino
Journal:  Infect Immun       Date:  2017-08-18       Impact factor: 3.441

Review 2.  Life on the inside: the intracellular lifestyle of cytosolic bacteria.

Authors:  Katrina Ray; Benoit Marteyn; Philippe J Sansonetti; Christoph M Tang
Journal:  Nat Rev Microbiol       Date:  2009-05       Impact factor: 60.633

3.  Hematopoietic MyD88 and IL-18 are essential for IFN-γ-dependent restriction of type A Francisella tularensis infection.

Authors:  Jerod A Skyberg; Carolyn A Lacey
Journal:  J Leukoc Biol       Date:  2017-09-26       Impact factor: 4.962

4.  Francisella acid phosphatases inactivate the NADPH oxidase in human phagocytes.

Authors:  Nrusingh P Mohapatra; Shilpa Soni; Murugesan V S Rajaram; Pham My-Chan Dang; Tom J Reilly; Jamel El-Benna; Corey D Clay; Larry S Schlesinger; John S Gunn
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

5.  AR-13, a Celecoxib Derivative, Directly Kills Francisella In Vitro and Aids Clearance and Mouse Survival In Vivo.

Authors:  Ky V Hoang; Haley E Adcox; James R Fitch; David M Gordon; Heather M Curry; Larry S Schlesinger; Peter White; John S Gunn
Journal:  Front Microbiol       Date:  2017-09-11       Impact factor: 5.640

6.  Discovery and Characterization of Two Classes of Selective Inhibitors of the Suppressor of the TCR Signaling Family of Proteins.

Authors:  Weijie Zhou; Yue Yin; Emery Smith; Jacqueline Chou; Justin Shumate; Louis Scampavia; Timothy P Spicer; Nicholas Carpino; Jarrod B French
Journal:  ACS Infect Dis       Date:  2018-12-14       Impact factor: 5.084

7.  Inhibitors of Ribosome Rescue Arrest Growth of Francisella tularensis at All Stages of Intracellular Replication.

Authors:  Tyler D P Goralski; Kalyan K Dewan; John N Alumasa; Victoria Avanzato; David E Place; Rachel L Markley; Bhuvana Katkere; Seham M Rabadi; Chandra Shekhar Bakshi; Kenneth C Keiler; Girish S Kirimanjeswara
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

Review 8.  Tularemia vaccines.

Authors:  Daniela Putzova; Iva Senitkova; Jiri Stulik
Journal:  Folia Microbiol (Praha)       Date:  2016-05-19       Impact factor: 2.099

9.  The Sensor Kinase QseC Regulates the Unlinked PmrA Response Regulator and Downstream Gene Expression in Francisella.

Authors:  Ky Van Hoang; James Fitch; Peter White; Nrusingh P Mohapatra; John S Gunn
Journal:  J Bacteriol       Date:  2020-10-08       Impact factor: 3.490

10.  Eradication of intracellular Francisella tularensis in THP-1 human macrophages with a novel autophagy inducing agent.

Authors:  Hao-Chieh Chiu; Shilpa Soni; Samuel K Kulp; Heather Curry; Dasheng Wang; John S Gunn; Larry S Schlesinger; Ching-Shih Chen
Journal:  J Biomed Sci       Date:  2009-12-09       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.